$0.0545
0.0004[0.74%]
Last update: 9:30AM Get Real Time Here
Bellerophon Therapeutics
(OTCPK:BLPH)Latest News for Bellerophon Therapeutics Stock (OTC:BLPH)
Bellerophon Therapeutics Stock (OTC: BLPH)
Categories: All
Friday, October 13, 2023
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga Insights - Oct 13, 2023, 5:31PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Oct 13, 2023, 1:31PM
- Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Oct 13, 2023, 1:14PM
- Dow Jumps Over 200 Points; JPMorgan Earnings Top EstimatesLisa Levin - Oct 13, 2023, 9:48AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Oct 13, 2023, 9:06AM
Thursday, October 12, 2023
Tuesday, October 10, 2023
Friday, July 28, 2023
Wednesday, July 26, 2023
Tuesday, July 25, 2023
- Crude Oil Up 1%; Verizon Earnings Beat ViewsLisa Levin - Jul 25, 2023, 2:31PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Jul 25, 2023, 1:31PM
- Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Jul 25, 2023, 1:11PM
- What's Happening With Bellerophon Therapeutics Stock Today?Vandana Singh - Jul 25, 2023, 12:53PM
- Dow Surges 50 Points; General Electric Profit Tops ExpectationsLisa Levin - Jul 25, 2023, 12:32PM
- Nasdaq Rises 70 Points; General Motors Posts Upbeat EarningsLisa Levin - Jul 25, 2023, 9:59AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Jul 25, 2023, 9:05AM
- Bellerophon Therapeutics shares are trading lower after the company received a delisting notice.Benzinga Newsdesk - Jul 25, 2023, 9:00AM
- Why Expion360 Holdings Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving PremarketLisa Levin - Jul 25, 2023, 8:26AM
- Bellerophon Therapeutics Would Be Delisted From NASDAQ At The Opening Of Business On July 28, 2023, Unless The Company Timely Requests A Hearing Before NASDAQ Hearings Panel To Address The Deficiencies And Present A Plan To Regain Compliance - 8KBenzinga Newsdesk - Jul 25, 2023, 5:28AM
Wednesday, July 05, 2023
Thursday, June 29, 2023
Tuesday, June 06, 2023
- The Latest Analyst Ratings for Bellerophon TherapeuticsBenzinga Insights - Jun 6, 2023, 5:01PM
- Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2023Benzinga Insights - Jun 6, 2023, 11:00AM
- HC Wainwright & Co. Maintains Buy on Bellerophon Therapeutics, Lowers Price Target to $2Benzinga Newsdesk - Jun 6, 2023, 6:35AM
- Laidlaw & Co. Downgrades Bellerophon Therapeutics to HoldBenzinga Newsdesk - Jun 6, 2023, 4:47AM
Monday, June 05, 2023
- Dow Drops Over 100 Points; Crude Oil RisesLisa Levin - Jun 5, 2023, 2:58PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Jun 5, 2023, 1:31PM
- Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Jun 5, 2023, 1:09PM
- Nasdaq Rises 70 Points; ISM Services PMI Drops In MayLisa Levin - Jun 5, 2023, 12:22PM
- Bellerophon Therapeutics Stock Nosedive: Here's WhyVandana Singh - Jun 5, 2023, 10:57AM
- US Stocks Mixed; SAIC Posts Upbeat ResultsLisa Levin - Jun 5, 2023, 9:47AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Jun 5, 2023, 9:06AM
- Bellerophon shares are trading lower after the company's Phase 3 REBUILD trial did not meet its primary endpoint.Benzinga Newsdesk - Jun 5, 2023, 7:48AM
- Bellerophon Therapeutics Shares Resume TradeBenzinga Newsdesk - Jun 5, 2023, 7:32AM
- Bellerophon Shares To Resume Trade At 7:30 AM ETCharles Gross - Jun 5, 2023, 7:13AM
- Bellerophon Says Phase 3 REBUILD Clinical Trial Did Not Meet Its Primary EndpointBenzinga Newsdesk - Jun 5, 2023, 7:01AM
- Bellerophon Therapeutics Shares Halted; Pending NewsCharles Gross - Jun 5, 2023, 6:57AM